(MENAFN) Drugmakers Novartis and GlaxoSmithKline said they plan multi-billion-dollar deals in pharmaceutical sector, involving US group Eli Lilly, according to Arab News.
The great deals will include Novartis sharpen its focus on the high-grossing cancer sector, GSK boost its share in vaccines and Eli Lilly strengthen its animal health unit.
Novartis also plans to buy GSK"s oncology business for USD16 billion in cash, while the Swiss group would sell its vaccines division, excluding flu vaccines, to the British company for USD7.1 billion.
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.